Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1011)	6/28/1999 2:10:00 PM
From: LLCF	Respond to of 1073

<Sheeesh! It was in WSJ, and we're still only at 4.2K shares?> The article was really just informative... talked about the science in a neutral light IMO, and part of the article was cynical about Reynolds having claimed a couple of years ago that Nicotine had limited pharmacological effects when the FDA was trying to regulate it as a drug. Now they come out and say the opposite. SIBI was just mentioned as another company looking into this area. DAK

To: scaram(o)uche who wrote (1011)	6/29/1999 9:32:00 AM
From: LLCF	Read Replies (1) \| Respond to of 1073

Almost forgot potential great news for the sector in yesterdays WSJ... Swiss stock exchange is starting a "neur markt" like Frankfurts, only it is exlusively for global biotechs!!!!!!!!! Anyone else see it? DAK